Increased infection rate after preemptive rituximab treatment for epstein-barr virus reactivation after allogeneic hematopoietic stem-cell transplantation
Anna D. Petropoulou, Raphael Porcher, Regis Peffault De Latour, Alienor Xhaard, Daniel Weisdorf, Patricia Ribaud, Paula Rodriguez-Otero, Félix Agbalika, Alexis Talbot, Antoine Toubert, Hélène Moins-Teisserenc, Maryvonnick Carmagnat, Gerard Socié, Marie Robin
Dive into the research topics of 'Increased infection rate after preemptive rituximab treatment for epstein-barr virus reactivation after allogeneic hematopoietic stem-cell transplantation'. Together they form a unique fingerprint.